NDC 52652-5001

Katerzia

Amlodipine

Katerzia is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is Amlodipine Benzoate.

Product ID52652-5001_2ddc59f1-dc68-420a-889b-245b54144430
NDC52652-5001
Product TypeHuman Prescription Drug
Proprietary NameKaterzia
Generic NameAmlodipine
Dosage FormSuspension
Route of AdministrationORAL
Marketing Start Date2019-08-15
Marketing CategoryNDA / NDA
Application NumberNDA211340
Labeler NameAzurity Pharmaceuticals, Inc.
Substance NameAMLODIPINE BENZOATE
Active Ingredient Strength1 mg/mL
Pharm ClassesCalcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 52652-5001-1

1 BOTTLE in 1 CARTON (52652-5001-1) > 150 mL in 1 BOTTLE
Marketing Start Date2019-08-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52652-5001-1 [52652500101]

Katerzia SUSPENSION
Marketing CategoryNDA
Application NumberNDA211340
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2019-08-15

Drug Details

Active Ingredients

IngredientStrength
AMLODIPINE1 mg/mL

OpenFDA Data

SPL SET ID:df673a4d-acb8-444c-a472-c87ab8cbd366
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2184120
  • 2184126
  • UPC Code
  • 9311612100110
  • Pharmacological Class

    • Calcium Channel Antagonists [MoA]
    • Dihydropyridine Calcium Channel Blocker [EPC]
    • Dihydropyridines [CS]
    • Calcium Channel Antagonists [MoA]
    • Dihydropyridine Calcium Channel Blocker [EPC]
    • Dihydropyridines [CS]

    NDC Crossover Matching brand name "Katerzia" or generic name "Amlodipine"

    NDCBrand NameGeneric Name
    52652-5001KaterziaAmlodipine
    33342-015AmlodipineAmlodipine
    33342-016AmlodipineAmlodipine
    0615-6582Amlodipine BesylateAmlodipine
    46287-035NORLIQVAamlodipine

    Trademark Results [Katerzia]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    KATERZIA
    KATERZIA
    88492580 not registered Live/Pending
    Argentum Holdings, LLC
    2019-06-27

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.